Table 4

Regression model estimates illustrating the association of disease activity with EQ-5D score differences (∆EQ-5D) between the general population and patients with RA (n = 2912). Estimates were adjusted for age, marital status, education level, body mass index, exercise, smoking status, disease duration, extraarticular features, joint surgery, IgM-rheumatoid factor status, comorbidities, and treatment with methotrexate, biological antirheumatic drugs and glucocorticoid.

Women, n = 2183Men, n = 729
DAS28CDAIDAS28CDAI
RemissionReferenceReferenceReferenceReference
Low0.07 (0.05–0.09)0.09 (0.07–0.11)0.07 (0.04–0.10)0.11 (0.09–0.13)
Moderate0.12 (0.11–0.13)0.17 (0.15–0.18)0.13 (0.11–0.16)0.20 (0.17–0.22)
High0.29 (0.27–0.32)0.28 (0.26–0.30)0.20 (0.16–0.24)0.22 (0.18–0.25)
R20.350.350.280.33
  • All estimates were statistically significant at the 0.001 level.